Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.11M.
ENTERPRISE VALUE (EV)
$5.11M
InMed Pharmaceuticals Inc.
Market Cap
$7.31M
Enterprise Value (EV)
$5.11M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $7.31M | $5.11M |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.19M | $7.20M |
| Co-Diagnostics, Inc. (CODX)vs › | $7.19M | $5.34M |
| Longeveron Inc. (LGVN)vs › | $7.15M | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | $4.41M |
| KALA BIO, Inc. (KALA)vs › | $7.04M | $6.81M |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | $7.73M |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | $6.36M |
Market Cap
$7.31M
Total Debt
$0.00
Cash
$2.19M
Enterprise Value
$5.11M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
